Amylin (1-37), human, amide;KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2(Disulfidebridge:2-7)

Amylin (1-37), human, amide;KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2(Disulfidebridge:2-7)

122384-88-7

C₁₆₅H₂₆₁N₅₁O₅₅S₂

human islet amyloid peptide ; diabetes-associatedpeptide (human) ; l-tyrosinamide,l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-,cyclic (2® ; amylin ; dap (human) ; human iapp ; l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-l-tyrosinamide, cyclic (2-7)-disulfide ; amlintide [usan:inn] ; iapp ; 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv ; amylin, human, amide ; diabetes-associated peptide amide human ; 7)-disulfide ; amylin, human ; iapp (human) ; amylin (human) ; ac 001 ; l-tyrosinamide, l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-, cyclic (2-7)-disulfide ; amylin, dap, iapp ; dap ; amlintide ; dap amide, human ; insulinoma ; human amylin